Swedbank AB Invests $8.65 Million in Astera Labs, Inc. $ALAB

Swedbank AB acquired a new stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 44,200 shares of the company’s stock, valued at approximately $8,654,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Fred Alger Management LLC grew its holdings in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after purchasing an additional 179,638 shares during the period. Hoey Investments Inc. grew its stake in Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after buying an additional 1,121 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its stake in Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after buying an additional 2,624 shares during the period. Wealth Effects LLC acquired a new stake in shares of Astera Labs in the second quarter worth $242,000. Finally, Maryland State Retirement & Pension System raised its stake in shares of Astera Labs by 37.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after acquiring an additional 1,906 shares during the period. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $167.26 on Friday. The business has a 50-day moving average of $159.77 and a 200-day moving average of $158.19. The company has a market capitalization of $28.25 billion, a PE ratio of 150.68, a P/E/G ratio of 3.12 and a beta of 1.51. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The business had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. During the same quarter in the previous year, the firm posted $0.23 earnings per share. The company’s revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other news, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $192.16, for a total transaction of $1,921,600.00. Following the completion of the sale, the general counsel owned 151,573 shares of the company’s stock, valued at approximately $29,126,267.68. This trade represents a 6.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Michael Truett Tate sold 11,430 shares of the company’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total transaction of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares in the company, valued at $27,823,452.93. This represents a 5.61% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 586,936 shares of company stock worth $89,331,140. 12.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on ALAB shares. Bank of America assumed coverage on shares of Astera Labs in a research report on Friday, October 3rd. They set a “neutral” rating and a $230.00 price target for the company. Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. BNP Paribas started coverage on Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating for the company. Roth Capital increased their target price on Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, TD Cowen dropped their target price on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a report on Wednesday, November 5th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $188.17.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.